Literature DB >> 19455395

Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

Rong Wang1, Cary P Gross, Stephanie Halene, Xiaomei Ma.   

Abstract

The potential role of socioeconomic status (SES) in the survival of patients with myelodysplastic syndromes (MDS) has not been evaluated. We conducted the first study to assess the prognostic role of neighborhood SES among a cohort of 2,118 patients (age >/= 66 years) who were diagnosed with incident MDS in the United States during 2001-2002. Principal component analysis was used to develop a summary SES score by combining multiple measures of neighborhood SES. The score was then used to classify the census tract each patient resided in into a category of high, medium, or low SES. Hazard ratios (HRs) were estimated using multivariate Cox proportional hazard models. After adjusting for age, gender, comorbidities, and histological subtypes, compared with MDS patients lived in high-SES census tracts, those resided in medium (HR = 1.14, 95% CI: 1.01-1.30) and low (HR = 1.17, 95% CI: 1.02-1.34) SES census tracts had significantly increased the risks of death. The impact of SES on survival was more apparent for patients with refractory anemia with ringed sideroblasts-patients residing in medium (HR = 1.85, 95% CI: 1.17-2.91) and low (HR = 2.06, 95% CI: 1.27-3.37) census tracts had a nearly two-fold increased the risk of mortality, compared with those living in high-SES census tracts. In conclusion, this population-based study suggests that neighborhood SES status is a significant and independent determinant of survival among elderly patients with MDS in the United States.

Entities:  

Mesh:

Year:  2009        PMID: 19455395      PMCID: PMC2921772          DOI: 10.1007/s10552-009-9362-7

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  31 in total

1.  Who is enrolled in for-profit vs. nonprofit Medicare HMOs?

Authors:  J Blustein; E C Hoy
Journal:  Health Aff (Millwood)       Date:  2000 Jan-Feb       Impact factor: 6.301

Review 2.  Risk-based management of myelodysplastic syndrome.

Authors:  David P Steensma; Ayalew Tefferi
Journal:  Oncology (Williston Park)       Date:  2007-01       Impact factor: 2.990

3.  Survival associated with treatment vs observation of localized prostate cancer in elderly men.

Authors:  Yu-Ning Wong; Nandita Mitra; Gary Hudes; Russell Localio; J Sanford Schwartz; Fei Wan; Chantal Montagnet; Katrina Armstrong
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

4.  Trends in end-of-life ICU use among older adults with advanced lung cancer.

Authors:  Gulshan Sharma; Jean Freeman; Dong Zhang; James S Goodwin
Journal:  Chest       Date:  2007-11-07       Impact factor: 9.410

5.  The link between neighborhood poverty and health: context or composition?

Authors:  D Phuong Do; Brian Karl Finch
Journal:  Am J Epidemiol       Date:  2008-08-06       Impact factor: 4.897

6.  Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.

Authors:  Cristina P Rodriguez; Rachid Baz; Rony Abou Jawde; Lisa A Rybicki; Matt E Kalaycio; Anjali Advani; Ronald Sobecks; Mikkael A Sekeres
Journal:  Leuk Res       Date:  2007-08-28       Impact factor: 3.156

7.  The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study.

Authors:  Tim E Byers; Holly J Wolf; Katrina R Bauer; Susan Bolick-Aldrich; Vivien W Chen; Jack L Finch; John P Fulton; Maria J Schymura; Tiefu Shen; Scott Van Heest; Xiang Yin
Journal:  Cancer       Date:  2008-08-01       Impact factor: 6.860

8.  Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland.

Authors:  Caroline Bray; David S Morrison; Pam McKay
Journal:  Leuk Lymphoma       Date:  2008-05

9.  Social inequality and incidence of and survival from Hodgkin lymphoma, non-Hodgkin lymphoma and leukaemia in a population-based study in Denmark, 1994-2003.

Authors:  Nina Roswall; Anja Olsen; Jane Christensen; Kathrine Rugbjerg; Lene Mellemkjaer
Journal:  Eur J Cancer       Date:  2008-07-25       Impact factor: 9.162

10.  Myelodysplastic syndromes: incidence and survival in the United States.

Authors:  Xiaomei Ma; Monique Does; Azra Raza; Susan T Mayne
Journal:  Cancer       Date:  2007-04-15       Impact factor: 6.860

View more
  5 in total

1.  Functional Principal Component Analysis of Spatio-Temporal Point Processes with Applications in Disease Surveillance.

Authors:  Yehua Li; Yongtao Guan
Journal:  J Am Stat Assoc       Date:  2014-08-01       Impact factor: 5.033

2.  Cigarette smoking shortens the survival of patients with low-risk myelodysplastic syndromes.

Authors:  Xiaomei Ma; Rong Wang; Naomi Galili; Susan T Mayne; Sa A Wang; Herbert Yu; Azra Raza
Journal:  Cancer Causes Control       Date:  2011-02-02       Impact factor: 2.506

Review 3.  Epidemiology of myelodysplastic syndromes.

Authors:  Xiaomei Ma
Journal:  Am J Med       Date:  2012-07       Impact factor: 4.965

4.  Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes.

Authors:  Rong Wang; Cary P Gross; Ronald J Maggiore; Stephanie Halene; Pamela R Soulos; Azra Raza; Naomi Galili; Xiaomei Ma
Journal:  Leuk Res       Date:  2010-11-09       Impact factor: 3.156

5.  The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes.

Authors:  Rong Wang; Cary P Gross; Kevin Frick; Xiao Xu; Jessica Long; Azra Raza; Naomi Galili; Jennifer Zikria; Yongtao Guan; Xiaomei Ma
Journal:  Leuk Res       Date:  2012-08-20       Impact factor: 3.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.